Health In Tech Stock Today

HIT Stock

1.82 0.05 2.82%

Health In Tech belongs to the Financials sector. EBITDA of about USD1.93 million represents core operating earnings. The company maintains approximately USD7.05 billion in cash. A current ratio of approximately 1.17x indicates adequate short-term liquidity.

Performance

Contained

Weak

Strong

Odds Of Distress

Low

High

Low

Health In shares are quoted at $1.82, delivering 2.82% up on the day with an intraday range between $1.64 and $1.86 after opening at $1.77. Based on structural risk metrics, Health In reflects a 9% probability of financial distress over the next few years. On a risk-adjusted basis, Health In has produced modest risk-adjusted performance over the last 90 trading days, consistent with contained return metrics. The performance scores are measured across the period from December 25, 2025 to March 25, 2026. Learn more.

Moving against Health Stock

0.78	WFC-PL	Wells Fargo	Pair Corr
0.76	BCH	Banco De Chile	Pair Corr
0.63	BAC-PL	Bank of America	Pair Corr
0.61	MMM	3M Company	Pair Corr
0.6	AVAL	Grupo Aval	Pair Corr
0.45	BAC	Bank of America Aggressive Push	Pair Corr

Follow Valuation Odds of Bankruptcy

Earnings Call Today

Stock Highlights

Health In Tech (HIT) is listed on NASDAQ Exchange in USA. The company runs in the Financials industry (Insurance sector). Health In Tech is categorized as small-cap based on a market capitalization of 102.44 M relative to financials. Further market cap context comes from about 45.21 M shares outstanding, operating in the Financials industry, and enterprise value near 95.14 M. The company has 184.49 K shares sold short (1.34 days to cover). Health In Tech has $206.69 K in debt with debt to equity (D/E) ratio of 1.14, which is consistent with its industry peers.

Health In financial stability analysis

Ownership Allocation Health In carries a majority of its outstanding shares held by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.61% of Health In outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months ahead of anticipated developments. Institutional investors hold approximately 5% of Health In's outstanding shares, with insiders holding 75% and 21% in the public float.

Check Health Ownership Details

Notable Updates

CEO Chairman	Tim Johnson
Old Names	[HIT Technologies Inc, Hitachi High-Tech Corporation]
Business Concentration	NASDAQ Composite, Financials, Insurance, Software - Application, Technology (View all Sectors)

Common Risk Profiles

The core principle of portfolio investing is achieving the best return per unit of risk. Health In market risk premium measures the excess return above the risk-free rate for a long position in Health In. The CAPM-based risk premium for Health In reflects compensation for systematic rather than idiosyncratic risk. Alpha and beta together help investors determine whether Health In offers fair compensation for its risk.

	Mean Deviation	4.65
	Semi Deviation	4.5
	Standard Deviation	5.99
	Variance	35.84

Health In Tech Against Markets

HIT		2.82	0%	100.0%	Health In Profile Health In Dashboard Technical analysis Backtest News Timeline
NYA		0.28	0%	9.0%	NYSE Composite Profile NYSE Composite Dashboard Technical analysis Backtest

Competition

Compare Correlations

Stock Overview, Methodology & Data Sources

Health In Tech is scheduled to announce its earnings today. manufactures and sells electronic and electrical solutions primarily in Asia, North America, and Europe. Health In employs 73 people. Headquarters are in 701 S. Colorado Ave, Stuart, FL, United States, 34994. Current valuation profile shows market cap 102.44 M, P/E 24.13, P/B 6.0. Health In operates in NASDAQ Composite. This profile combines financial reporting with risk and trading context. Historical performance suggests relatively contained downside variability.

Methodology

Unless otherwise specified, financial data for Health In Tech is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Health (USA Stocks:HIT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Health In Tech may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board

Last reviewed on March 19th, 2026

Health In Corporate Management

Del Lockett	Chief Officer	Profile
Glenn Hillyer	Senior Relations	Profile
Jennifer Guerrica	Chief Officer	Profile
Lori Babcock	Chief Staff	Profile
Michael Clarkson	Chief Officer	Profile

Additional Tools for Health Stock Analysis

	Portfolio Prophet Use AI to generate optimal portfolios and find investment opportunities
	FinTech Suite Use AI to screen and filter investment opportunities
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	CEOs Directory Screen CEOs from public companies around the world
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets

Macroaxis provides analytical tools and reference data for investors of all levels to evaluate holdings and assess risk across market volatility, economic shifts, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC